BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22016468)

  • 21. Oncogenic role of long noncoding RNA AF118081 in anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide-transformed 16HBE cells.
    Yang Q; Zhang S; Liu H; Wu J; Xu E; Peng B; Jiang Y
    Toxicol Lett; 2014 Sep; 229(3):430-9. PubMed ID: 25050996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
    Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
    BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene.
    Zhao P; Fu J; Yao B; Song Y; Mi L; Li Z; Shang L; Hao W; Zhou Z
    Toxicol In Vitro; 2012 Mar; 26(2):362-8. PubMed ID: 22227536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
    Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y
    Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
    Pekow J; Meckel K; Dougherty U; Butun F; Mustafi R; Lim J; Crofton C; Chen X; Joseph L; Bissonnette M
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(3):G179-87. PubMed ID: 25477374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.
    Wang YY; Ren T; Cai YY; He XY
    Cancer Biother Radiopharm; 2013 Mar; 28(2):131-7. PubMed ID: 23134218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol and prostate cancer: promising role for microRNAs.
    Dhar S; Hicks C; Levenson AS
    Mol Nutr Food Res; 2011 Aug; 55(8):1219-29. PubMed ID: 21714127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.
    García-Cruz R; Camats M; Calin GA; Liu CG; Volinia S; Taccioli C; Croce CM; Bach-Elias M
    BMC Med Genet; 2015 Jul; 16():46. PubMed ID: 26138095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
    Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
    Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
    Lang Q; Ling C
    Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).
    Sun D; Yu F; Ma Y; Zhao R; Chen X; Zhu J; Zhang CY; Chen J; Zhang J
    J Biol Chem; 2013 Mar; 288(13):9508-18. PubMed ID: 23322774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
    Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
    Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of miR-21 by Ras in vivo and its role in tumor growth.
    Frezzetti D; De Menna M; Zoppoli P; Guerra C; Ferraro A; Bello AM; De Luca P; Calabrese C; Fusco A; Ceccarelli M; Zollo M; Barbacid M; Di Lauro R; De Vita G
    Oncogene; 2011 Jan; 30(3):275-86. PubMed ID: 20956945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
    Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
    Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells.
    Mollerup S; Ovrebø S; Haugen A
    Int J Cancer; 2001 Apr; 92(1):18-25. PubMed ID: 11279601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.